Borregaard's operating revenues were NOK 1,799 million (NOK 1,949 million)(2) in
the 3(rd) quarter of 2025. EBITDA(1) was NOK 440 million (NOK 524 million). The
result in BioSolutions increased while BioMaterials and Fine Chemicals had lower
results compared with the 3(rd) quarter of 2024.
The reduced EBITDA(1) was due to lower bioethanol prices and the temporary
disruption in cellulose production at the Sarpsborg site. The negative impact
from this disruption amounts to approximately NOK 40 million. The improvement in
the result for BioSolutions was attributable to sustained growth in sales to
agriculture. In BioMaterials, higher sales prices were more than offset by lower
sales volume. Fine chemical intermediates delivered a strong result. Net
currency effects were positive across all areas.
Profit before tax was NOK 247 million (NOK 326 million). Earnings per share were
NOK 1.96 (NOK 2.51).
We are pleased with the strong development in agricultural sales and our ability
to deliver solid results during uncertain global conditions. This demonstrates
the strength and flexibility of Borregaard's business model, says CEO Tom Erik
Foss-Jacobsen.
Contacts:
CFO Per Bjarne Lyngstad, +47 952 44 515
Director Communications, Tone Horvei Bredal, +47 924 67 711
1. Operating profit before depreciation, amortisation and other income and
expenses
2. Figures in parentheses are for the corresponding period in the preceding year
This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.
This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 22 October 2025 at 07:00 CEST.